DAFNA Capital Management »

Silverback Therapeutics shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 148k 14.50
2024-06-30 $2.0M 239k 8.51
2024-03-31 $2.4M 239k 10.22
2023-12-31 $1.7M 311k 5.48